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Abstract Mutations in PROP1 are a common genetic
cause of multiple pituitary hormone deﬁciency (MPHD).
We used a comparative genomics approach to predict the
transcriptional regulatory domains of Prop1 and tested
them in cell culture and mice. A BAC transgene containing
Prop1 completely rescues the Prop1 mutant phenotype,
demonstrating that the regulatory elements necessary for
proper PROP1 transcription are contained within the BAC.
We generated DNA sequences from the PROP1 genes in
lemur, pig, and ﬁve different primate species. Comparison
of these with available human and mouse PROP1 se-
quences identiﬁed three putative regulatory sequences that
are highly conserved. These are located in the PROP1
promoter proximal region, within the ﬁrst intron of
PROP1, and downstream of PROP1. Each of the conserved
elements elicited orientation-speciﬁc enhancer activity in
the context of the Drosophila alcohol dehydrogenase
minimal promoter in both heterologous and pituitary-de-
rived cells lines. The intronic element is sufﬁcient to confer
dorsal expansion of the pituitary expression domain of a
transgene, suggesting that this element is important for the
normal spatial expression of endogenous Prop1 during
pituitary development. This study illustrates the usefulness
of a comparative genomics approach in the identiﬁcation of
regulatory elements that may be the site of mutations
responsible for some cases of MPHD.
Introduction
All vertebrates have pituitary glands composed of spe-
cialized hormone-producing cells (Matsumoto and Ishii
1987). The individual hormones are evolutionarily con-
served, although their function varies across the classes of
Animalia. This conservation suggests that genetic regula-
tion of pituitary function may be conserved.
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DOI 10.1007/s00335-007-9008-6In humans, growth insufﬁciency resulting from pituitary
hormone deﬁciency is not infrequent, occurring in
approximately 1 in 4000 live births (Procter et al. 1998;
Vimpani et al. 1977). Growth hormone (GH) insufﬁciency
is the most common type of dwarﬁsm and usually results
from mutations in the GH gene cluster (Braga et al. 1986;
Mullis et al. 1990). Multiple pituitary hormone deﬁciencies
(MPHD) result from mutations in transcription factors
important for the normal development and function of the
pituitary gland, including POU1FI (PIT1), Prophet of PIT1
(PROP1), HESX1, LHX3, LHX4, and SOX3 (Bhangoo et al.
2006; Cogan et al. 1998; Laumonnier et al. 2002; Machinis
et al. 2001; Mendonca et al. 1999; Netchine et al. 2000;
Pfa ¨fﬂe et al. 1992; Radovick et al. 1992; Tajima et al.
2003; Wu et al. 1998). The ﬁrst transcription factor to be
linked to MPHD was PIT1 (Tatsumi et al. 1992). Patients
with mutations in PIT1 generally have deﬁciencies in GH,
prolactin (PRL), and thyroid-stimulating hormone (TSH)
as well as profound pituitary hypoplasia (Cohen et al.
1996). Mutations in PROP1 are a common genetic cause of
familial MPHD. Patients with PROP1 mutations exhibit
progressive hormone loss with varying age of onset and
severity (Bottner et al. 2004; Fluck et al. 1998). Most
common are deﬁciencies in PRL, GH, and TSH as well as
follicle-stimulating hormone (FSH) and luteinizing hor-
mone (LH) (Agarwal et al. 2000; Deladoey et al. 1999).
Progressive adrenocorticotrophic hormone (ACTH) loss
presents as late as the third decade of life (Bottner et al.
2004). Some MPHD cases, however, cannot be traced to
mutations in the protein-coding or intron-exon splice sites
in the DNA sequence of known genes important for pitu-
itary development.
The mechanism of PROP1 action has been studied
extensively in two mouse models, the Ames dwarf
(Prop1
df) and the Prop1
null (Nasonkin et al. 2004; Ward
et al. 2005). In mice, Prop1 is expressed throughout the
developing Rathke’s pouch in a dorsal to ventral expres-
sion gradient from about embryonic day 10 (e10) until
about e16 (Sornson et al. 1996). PROP1 transcripts are
present in the adult pituitaries of human and pig, although
the levels were not quantiﬁed relative to the embryonic
pituitary (Nakamura et al. 1999a, 1999b; Skelly et al. 2000;
Sloop et al. 2000; Usui et al. 2000). A number of Prop1
downstream targets have been identiﬁed, including Pit1,
Hesx1, Tle3, and Notch2 (Brinkmeier et al. 2003; Gage
et al. 1996a; Raetzman et al. 2004).
It is of great interest to identify the transcriptional reg-
ulators of Prop1 because it is pituitary-speciﬁc, unlike
many of the other key regulators of pituitary development:
Pitx1, Pitx2, Lhx3, Lhx4, and Hesx1. Each of these genes is
expressed prior to Prop1 and is a candidate for transcrip-
tional regulation of Prop1. Prop1 expression is activated in
Pitx1 and Pitx2 single mutants, but this may be due to the
ability of Pitx1 and Pitx2 to compensate for each other
(Suh et al. 2002; Szeto et al. 1999). Prop1 expression also
appears to be initiated normally in Hesx1- and Lhx4-deﬁ-
cient mice (Dasen et al. 2001; Raetzman et al. 2002). Thus,
the spatial and temporal regulation of Prop1 expression is
not fully explained by these genes, suggesting that addi-
tional factors may be involved.
The regulation of gene expression involves the cooper-
ation of a variety of transcription factors in a tissue-,
temporal-, and/or spatial-speciﬁc fashion that interact with
cis-acting regulatory elements in DNA sequences (Kleinjan
and van Heyningen 2005). The identiﬁcation of these ele-
ments can be difﬁcult because they may be located at a
considerable distance from the gene or even within the
introns of neighboring genes (Bagheri-Fam et al. 2001;
Lang et al. 2003; Lettice et al. 2003). The identiﬁcation of
these elements is facilitated by comparative genomics in
the form of cross-species DNA comparisons. The align-
ment of the DNA sequences of orthologous genes from
different species, both closely and distantly related, can
reveal potential conserved regulatory elements that can
then be analyzed in vivo (Boffelli et al. 2004; Nobrega and
Pennacchio 2004; Pennacchio and Rubin 2001). Tran-
scription factors involved in development, like Prop1, are
often conserved among vertebrates, and their regulatory
sequences are also likely to be conserved (Plessy et al.
2005).
In this study we report the sequence of the PROP1 gene
from several mammals and utilize cross-species PROP1
protein sequence comparison to verify the conservation of
the functional domains of the protein and use genomic
sequence comparison to identify putative transcriptional
regulatory elements in the noncoding regions of the Prop1
gene. This analysis revealed the presence of three con-
served noncoding elements within and near the gene. Each
of them exhibited orientation-dependent enhancer activity
in tissue culture, and an element in intron 1 conferred tis-
sue-speciﬁc and unique spatial expression in transgenic
mice. These studies establish a functional role for the in-
tronic element in Prop1 gene regulation. Finally, using
bacterial artiﬁcial chromosome (BAC) transgene rescue of
the Prop1 mutant phenotype, we demonstrate that all of the
sequences necessary for functional expression of Prop1 are
located within the BAC.
Materials and methods
Protein and DNA sequence
A BAC clone of approximately 200 kb and containing the
pig (Sus scrofa) Prop1 gene was identiﬁed, and DNA was
isolated from it. A shotgun sequencing library was pre-
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123pared from that BAC by using SeqWright (Houston, TX),
and the resulting subclones were sequenced at the Uni-
versity of Michigan Sequencing Core using Applied Bio-
systems (Foster City, CA) sequencers (Model 3700) and
BigDye V1.1 terminator chemistry, according to standard
manufacturer’s protocols. Sequence assembly of the shot-
gun sequence data was performed using phred and phrap
(Ewing and Green 1998), and consed (Gordon et al. 1998),
resulting in 6X draft sequence coverage. Limited ﬁnishing
was performed based on the ‘‘autoﬁnish’’ option in consed
to close some gaps, especially those in the vicinity of the
Prop1 gene. A total of ten draft contigs of 1 kb or greater
were obtained in the ﬁnal assembly, accounting for 196 kb,
or an estimated 98% of the original BAC. The sequences
have a phred Q-score of 20 or higher, with the majority
being Q40 or better. The BAC sequences were submitted to
GenBank (NCBI; http://www.ncbi.nlm.nih.gov; accession
number EF590118). One contig of approximately 26.3 kb
contained the Sus scrofa Prop1 gene, including 13.8 kb of
5¢ ﬂanking sequence, 3.7 kb encoding the Prop1 gene, and
8.7 kb of 3¢ ﬂanking sequence. A set of lemur BACs
containing the Prop1 gene were isolated from a library
derived from a cell line of the ring-tailed lemur (Lemur
catta; AG07100C, Coriell Cell Repositories, Camden, NJ)
using a human PROP1 exon 3 probe. One lemur BAC,
LBNL-2 102B17, was sequenced from ends of 3 kb sub-
clones to approximately tenfold coverage using BigDye
terminators (Applied Biosystems) and assembled into or-
dered and oriented contigs with the Phred-Phrap-Consed
suite (Ewing and Green 1998; Gordon et al. 1998). The
assembled BAC sequence was submitted to GenBank with
accession number AC162436. Prop1 gene sequence from
gorilla (Gorilla gorilla), Black and Red Howler (Alouatta
belzebul), Brown Capuchin (Cebus apella), and Gelada
Baboon (Theropithecus gelada) was ampliﬁed from geno-
mic DNA (gift from Dr Deborah Gumucio, University of
Michigan, Ann Arbor, MI) by using the forward primer (5¢-
CCTGCTCCCAGGAGGGGATT-3¢) that corresponded to
the human PROP1 5¢ ﬂanking sequence that was highly
conserved between mouse and human, and as the reverse
primer (5¢-AGGCTGGGGATCACCTTGGTG-3¢) that
corresponded to the 3¢ UTR of the human PROP1 gene.
cDNA sequence was determined by using the high con-
servation between primate exon splice acceptor/donor sites
to assemble the cDNA sequence from the gene sequence.
The protein sequence was then translated from the cDNA
as described above. The Prop1 gene sequences were
deposited in GenBank with accession numbers DQ177426
for gorilla, DQ177425 for capuchin monkey, DQ177427
for howler monkey, and DQ177424 for baboon.
The 20-kb human PROP1 was obtained from the human
chromosome 5 contig sequences from GenBank accession
numbers NT086684 and NT023133. The 20-kb mouse
(Mus musculus) Prop1 sequence was obtained from the
mouse chromosome 11 contig sequences from GenBank
accession number NT096135. The Prop1 genomic se-
quence for the chimpanzee (Pan troglodytes) was obtained
via the Berkley Genome Pipeline from the genome VISTA
analysis program [http://www.genome.lbl.gov/vista/in-
dex.shtml (Couronne et al. 2003)]. The cDNA and protein
sequences were determined as described above. The Prop1
genomic sequence for the rat and partial genomic sequence
for the fugu (Fugu rubripes) and zebraﬁsh (Danio rerio)
were obtained by searching the UCSC genome browser
[http://www.genome.ucsc.edu (Kent 2002)] for the closest
matches to PROP1. The partial protein sequences for the
fugu and zebraﬁsh were determined by the translation of
the partial gene sequence in all three frames to identify the
PROP1 homedomain and transactivation domain sequence.
The rat (Rattus norvegicus) cDNA sequence was obtained
from GenBank (accession number NM153627) and trans-
lated as described above. Prop1 genomic sequence was
obtained for the dog (Canis familiaris; AF126157) and
sheep (Ovis aries; AY533708) and PROP1 protein se-
quence for human (NP006252), pig (NP001001263), cow
(Bos taurus; NP777103), sheep (NP001009767), mouse
(P97458), dog (NP001018643), and partial protein se-
quence for the chicken (Gallus gallus; AB037110) was
obtained from the NCBI website.
Sequence analysis
ClustalW alignment for protein and DNA sequences were
done with the LASERGENE Navigator Meg align se-
quence alignment program (DNASTAR Inc., Madison,
WI). Mouse, rat, human, and chimp chromosome com-
parisons were done using the University of California,
Santa Cruz (UCSC) genome browser [http://www.geno-
me.ucsc.edu (Kent et al. 2002)]. The pig Prop1 BAC
contigs were compared to the mouse genome using the
genome VISTA program [http://www.genome.lbl.gov/vis-
ta/index.shtml (Couronne et al. 2003)]. The 20-kb PROP1
genomic sequences for the human, lemur, pig, and mouse
were analyzed with the mVISTA [http://www.geno-
me.lbl.gov/vista/index.shtml (Bray et al. 2003)] compara-
tive genomics program to determine the identity of the
conserved noncoding elements.
Plasmid construction
The CE-A/LacZ plasmid was constructed for the targeted
knockout of the Prop1 gene (Nasonkin et al. 2004). The
CE-B + CE-A/LacZ plasmid was constructed by digesting
the CE-A/LacZ plasmid with XhoI and subcloning the re-
gion containing 3 kb of the Prop1 5¢ ﬂanking region, the
LacZ coding region, and mouse protamine 1 splice and
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123polyadenylation regions into the XhoI site of pBluescript
SK+ (Stratagene, La Jolla, CA). A 9.5-kb Prop1 genomic
clone (Nasonkin et al. 2004), which was generated from a
P1 clone containing the entire Prop1 gene, was used as a
template to amplify the CE-B region with a series of
primers that engineered ﬂanking loxP sites (5¢-ATAAC
TTCGTATAGCATACATTATACGAAGTTAT-3¢). The
ﬂoxed CE-B fragment was subcloned into pGEM-T Easy
(Promega, Madison, WI). This CE-B loxP construct was
digested with NotI/XbaI and ligated into the NotI/XbaI sites
of the pBluescript SK+ vector that contained the 3-kb
Prop1 5¢ ﬂanking sequence with the LacZpA reporter.
The aGsu-Prop1DCE-B plasmid was made by creating a
chimera of the Prop1 intron 1 in which the CE-B region was
deleted. First, the intron sequence for the 5¢ ﬂank of CE-B
was ampliﬁed from the 9.5-kb Prop1 genomic clone (Na-
sonkin et al. 2004) by using primers (5¢-GGTTTGGGTG
GCTAGCCATGGAA-3¢ and 5¢-TTCCCAAGCACCTCC
TTCATATCCCACCCCCCAACTAAGCACCC-3¢) that
allowed this fragment to be annealed to the CE-B 3¢ﬂanking
sequence that was also ampliﬁed from the 9.5-kb Prop1
plasmid with the primers 5¢-CCTCCTATAAGCCTCAGA
GCT-3¢ and 5¢-GGGTGCTTAGTTGGGGGGTGGGATAT
GAAGGAGGTGCTTGG G-3¢. These two PCR products
were engineered with overlapping tails that could be an-
nealed together to create a chimeric Prop1 intron1 with the
CE-B region deleted. This chimera was ampliﬁed with the
primers 5¢-GGTTTGGGTGGCTAGCCATGGAA-3¢ and
5¢-CCTCCTATAAGCCTCAGAGCT-3¢, digested with
NcoI and SacI, and subcloned into the aGsu-Prop1 plasmid
(Cushman et al. 2001) to create the desired transgenic con-
struct. This aGsu-Prop1DCE-B was subcloned into pBlue-
script SK+ by an EcoR1 partial digest. The CE-B + aGsu-
Prop1DCE-B plasmid was made by amplifying the CE-B
loxP region from the CE-B + CE-A/LacZ plasmid with the
primers 5¢-GGTATCGATTACCCTAGAGGGCAGTGCA
GTGCCTG-3¢ and 5¢-GGAATCGATATCTCTTTGCTGT
CTATCAATGACGT-3¢ that engineered ClaI sites at the
endsofthePCRproducttoallowthesubcloningofthisCE-B
loxP region into the ClaI site of aGsu-Prop1DCE-B.
The 584-bp CE-A region was ampliﬁed from the 9.5-kb
Prop1 genomic clone with primers to engineer HindIII
sites at the ends the sequence (5¢-GTCTGGAAGCTTGC
TGGTGAGGCTG-3¢ and 5¢-GGAAGCTTGTCTTGGAG
AAGAGACCTCCTCCTGG-3¢) and subcloned in both the
forward and reverse orientations into the HindIII site of the
pDeltaODLO 02 plasmid (Iniguez-Lluhi et al. 1997) ob-
tained from Dr. Jorge Iniguez-Lluhi (University of Michi-
gan, Ann Arbor, MI) that contained the Drosophila alcohol
dehydrogenase (ADH) minimal promoter and the ﬁreﬂy
luciferase reporter gene. The 508-bp CE-B region was PCR
ampliﬁed from the 9.5-kb Prop1 plasmid with primers that
engineered EcoRI sites at the ends (5¢-CGGAAGAATT
CTGGTTGCCCAAGGTCC-3¢ and 5¢-GCCACTCGCAGA
ATTCATTTC-3¢) and subcloned into pBluescript (Strata-
gene) at the EcoRI site. The CE-B was then digested with
SmaI/KpnI and subcloned onto a version of pGL3basic
(Promega) that contained the TK minimal promoter in-
serted into the BglI/HindIII sites. The CE-B region was
released from this plasmid by digestion with XhoI and
subcloned into the XhoI site of pDeltaODLO 02 in both the
reverse and forward orientations. The 1196-bp CE-C re-
gion was ampliﬁed from the 9.5-kb plasmid (5¢-GGA
GTACTGGGACCCTTAAGGCCCTTGGGCTGCAGG-3¢
and 5¢-GGAGTACTGGAGTCTGAGACAGGAAGACTG
AGAG-3¢), cloned in to the pGEM-T Easy vector (Pro-
mega), digested with NotI, and subcloned into the NotI site
of pDeltaODLO 02 in the forward and reverse orientations.
Cell culture
Monkey ﬁbroblast CV-1 cells (American Type Culture
Collection, Manassas, VA), mouse pituitary gonadotrope
aT3-1 cells (Dr. Pamela Mellon, University of San
Diego, La Jolla, CA), rat anterior pituitary GH3 cells,
and mouse pituitary corticotrope AtT-20 cells were
maintained at 37 C/5% CO2 in Dulbecco’s Modiﬁed
Eagle Medium (Invitrogen, Carlsbad, CA) supplemented
with 10% heat inactivated fetal bovine serum (Hyclone,
Logan, UT) and 100 units/ml penicillin-streptomycin
(Invitrogen). The GH3 and AtT-20 cell lines were ob-
tained from Dr. Audrey Seasholtz (University of Michi-
gan, Ann Arbor, MI).
Transient transfection and Dual-Luciferase
  Reporter
Assay
Cells were plated onto 24-well plastic plates (Fisher Sci-
entiﬁc, Fair Lawn, NJ) at a density of 0.4 · 10
5 cells/well
for CV-1, 0.7 · 10
5 cells/well for aT3-1, 1.0 · 10
5 cells/
well for GH3, and 1.2 · 10
5 cells/well for AtT-20 cells,
such that cells were 40%–60% conﬂuent the next day.
DNA cocktails totaling 0.3 lg/well [0.08 lg enhancer
construct, 0.218 lg pBluescript SK+, 0.002 lg (cytomeg-
alovirus) CMV-Renilla luciferase (Promega) internal con-
trol in 400 ll serum-free DMEM] were transfected into
cultured cells using Fugene 6 (Roche, Indianapolis, IN) at a
12:5 ratio according to the manufacturer’s protocol. The
pDeltaODLO 02 plasmid that contains the ADH minimal
promoter with the ﬁreﬂy luciferase reporter gene was used
as a negative control and determined as basal level. Forty-
eight hours after transfection, Dual-Luciferase Reporter
Assay (Promega) was performed according to the manu-
facturer’s protocol and measured using the Lmax Micro
plate Illuminometer (Molecular Devices, Sunnyvale, CA)
with the SOFTmax Pro software (Molecular Devices). The
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internal control. All assays were done in triplicate and the
results were repeated a total of three times. Results were
averaged and expressed as percent activity over basal.
Maintenance, generation, and genotyping of transgenic
mice
To generate the BAC transgenic mice, BAC RP23-250I22
(supplied by Pieter J. de Jong, Childrens Hospital Oakland
Research Institute) was puriﬁed over a Nucleobond AX
column (BD (Biosciences) and injected into pronuclei of
fertilized eggs generated from a cross between DF/B-
Prop1
df/+ males of mixed genetic background (Buckwalter
et al. 1991) and (SJL/J · C57BL/6J) F1 females. BAC
transgenic; Prop1
df/+ mice were crossed to N6-B6-Prop1
+/–
mice (Nasonkin et al. 2004) to generate BAC transgenic;
Prop1
df/- offspring. These mice and all littermates were
weighed, photographed, and genotyped at weaning.
The presence of the BAC was assessed by PCR using
primers designed to amplify products that span the junction
between the BAC backbone and the mouse genomic DNA
(Sp6 end 5¢-CATATTTTCCCCATCCACCACCAT-3¢ and
5¢-TTCCCGCAAGAGCAAACACAAC-3¢; T7 end 5¢-CC
GGAAGGAGCTGACTGGGTTGA-3¢ and 5¢-TGGGCAT
TGAGCTTTCTGGGTTTT-3¢). Previously described
primers were used to genotype the Prop1
df allele (Cushman
et al. 2001) and Prop1 null allele (Nasonkin et al. 2004).
The aGSU Prop1 transgenic mouse lines TgN(Cga-
Prop1)
D4Sac and TgN(Cga-Prop1)
D6Sac (Cushman et al.
2001; Vesper et al. 2006) have been maintained in the
mouse facility at the University of Michigan. Newborns
were obtained by mating transgenic males of the D4 or D6
aGsu-Prop1 transgenic lines with C57BL/6J females (The
Jackson Laboratory, Bar Harbor, ME). Genomic DNA was
prepared from tail biopsies of all progeny born and then
screened for the aGsu-Prop1 transgene as previously de-
scribed (Cushman et al. 2001).
To create transient transgenic mice with various Prop1
plasmids, inserts were released from the plasmid vector
sequences and puriﬁed for microinjection. The 7.7-kb
aGsu-Prop1DCE-B fragment was generated by digestion of
the aGsu-Prop1DCE-B plasmid with NotI/ClaI. The 8.0-kb
CE-B + aGsu-Prop1DCE-B fragment was generated by the
digestion of the CE-B + aGsu-Prop1DCE-B plasmid with
NotI/ApaI. Both inserts were isolated by agarose gel elec-
trophoresis and puriﬁed with the Nucleospin Extract Kit
(Clontech, Mountain View, CA). Microinjection and
transplantation were performed as previously reported
(Cushman et al. 2001). Genomic DNA was prepared from
tail biopsies of all progeny born and then screened for the
transgene using the same genotyping strategy as for the
aGsu-Prop1 (Cushman et al., 2001).
The 7-kb CE-A/LacZ fragment was generated by
digestion of the CE-A/LacZ plasmid with XhoI. The 8.5-kb
CE-B + CE-A/LacZ plasmid was generated by digestion of
the CE-B + CE-A/LacZ plasmid with NotI/ScaI. Microin-
jection and transplantation were performed as described
above. To detect both transgenes, a 250-bp product was
ampliﬁed from the genomic DNA using the Prop1-speciﬁc
primer (5¢-GTGAGAAAACAGGTATCTAGCT-3¢) and
the LacZ-speciﬁc primer (5¢-CCACTTTGCGTTTCTTGG-
3¢). Reactions were performed for 33 cycles of PCR con-
ditions: 93 C for 3 min · 1, (94 C for 30 sec, 55 C for 45
sec, 72 C for 20 sec), 72 C for 5 min.
All mice were housed in a 12-h light, 12-h dark cycle
with unlimited access to tap water and Purina 5008 or 5020
chow. All procedures using mice were approved by the
University of Michigan Committee on Use and Care of
Animals, and all experiments were conducted in accordance
with the principles and procedures outlined in the NIH
Guidelines for the Care and Use of Experimental Animals.
Analysis of transgenic animals
Embryos were harvested on e12.5 from surrogate mothers
carrying CE-B + CE-A/LacZ transient transgenics and
quick frozen on dry ice. Cryosections of 12–15 lm were
prepared on slides and ﬁxed in 0.5% glutaraldehyde, 1.25
mM EGTA, 2 mM MgCl2, and PBS (pH 7.2) for 5 min at
room temperature, washed three times in 0.02% NP-40
(Amersham Pharmacia Biotech, Inc., Piscataway, NJ), 100
mM sodium phosphate, 2 mM MgCl2 wash buffer, and
stained for b-galactosidase activity overnight at 37 Ci na
solution of 1 mg/ml X-gal (Roche), 5 mM K3Fe(CN)6,5
mM K4Fe(CN)6, 2 mM MgCl2, and 0.02% NP-40 in PBS.
P1 heads from aGsu-Prop1, aGsu-Prop1DCE-B, CE-
B+aGsu-Prop1DCE-B, and nontransgenic controls; e12.5
embryos from CE-A/LacZ, CE-B+CE-A/LacZ, and con-
trols; or e12.5/e14.5 embryos from wild-type animals were
harvested and ﬁxed for 2-24 h in 4% paraformaldehyde in
PBS (pH 7.2) followed by PBS wash, dehydration in a
graded series of ethanol, and parafﬁn embedding. Six-
micrometer sections were prepared on slides and washed in
0.3% Triton X-100 (Sigma, St. Louis, MO) in PBS (pH
7.2) for 15 min at room temperature, permeablized by
proteinase K digestion (0.8 lg/ml in 100 mM Tris-HCl, 50
mM EDTA pH 8.0) for 15 min at 37 C, followed by a 5-
min ﬁxation in 4% paraformaldehyde in PBS (pH 7.2). To
acetylate sections, tissues were exposed to 0.1 M trietha-
nolamine, 0.25% acetic anhydride solution for 10 min.
Tissues were prehybridized in hybridization buffer [50%
formamide, 5· SSC, 2% blocking powder (Roche Molec-
ular Biochemicals), 0.1% Triton X-100 (Sigma), 0.5%
CHAPS (Sigma), 1 mg/ml yeast tRNA, 5 mM EDTA (pH
8.0), and 50 lg/ml heparin]. Tissues were then hybridized
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123overnight at 55 C with the either the Prop1 or mP1 probe
diluted in hybridization buffer.
The Prop1 riboprobe was generated as previously de-
scribed (Cushman et al. 2001). The mP1 riboprobe was
generated by subcloning the mP1 polyA region from a
modiﬁed version of the pnlacF plasmid into pBluescript
SK+ (Stratagene) at the BamHI and BglII sites (Peschon
et al. 1987). The clone was linearized by digestion with
BamHI to generate the antisense probe. The Prop1 and
mP1 riboprobes were generated and labeled with digoxig-
nenin (Roche Molecular Biochemicals) following standard
procedures (Mannheim 1996).
Nontransgenic P1 pituitaries were analyzed for aGSU
expression with a polyclonal rabbit anti-rat aGSU antibody
(1:1800; National Institute of Diabetes and Digestive
Kidney Diseases, Torrance, CA) and detected with a bio-
tin-conjugated anti-rabbit IgG (1:400; Vector Laboratories,
Burlingame, CA) using the Vectastain ABC kit (according
to manufacturer’s protocol; Vector Laboratories).
PIT1 immunohistochemistry was preformed on 6-lm
parafﬁn sections of dissected pituitary tissue as described
(Charles et al. 2005).
All images were captured with a Leitz DMRB micro-
scope (W. Nuhsbaum, Inc., McHenry, IL) and an Optronics
(Goleta, CA) camera.
Results
PROP1 protein conservation
In humans, PROP1 comprises three exons that encode a
226-amino-acid protein that contains a DNA-binding
homeodomain and a transactivation domain at the C-ter-
minus. Previous studies comparing the bovine PROP1
protein sequence to that of other mammals revealed that
the homeodomain is highly conserved whereas the N-ter-
minus is not (Guy et al. 2004; Showalter et al. 2002). To
obtain PROP1 protein sequences from several species for
comparison, we designed primers to regions of the PROP1
gene sequence exhibiting high conservation between
mouse and human. We used these primers to amplify
genomic DNA from capuchin monkey, howler monkey,
gorilla, and baboon. We sequenced the ampliﬁcation
products, aligned the genomic sequences, and compared
them. The splice junctions are highly conserved, which
permitted prediction of the cDNA and protein sequence
(see Materials and methods).
Human PROP1 protein sequence was compared to the
PROP1 protein sequence of various primate species, which
are close relatives of humans, ranging from the hominoid
primate clade, which shared a common ancestor with hu-
mans about 6–8 million years ago, to old-world and new-
world monkeys which diverged approximately 25 and 40
million years ago, respectively (Nei et al. 2001; Nobrega
and Pennacchio 2004). Human PROP1 protein sequence
was also compared to the PROP1 protein sequence of more
distantly related mammals. We selected the lemur (Lemur
catta), which is a prosimian of intermediate evolutionary
distance, having diverged from human about 60 million
years ago (Boffelli et al. 2003), and more distantly related
mammalian species such as artiodactyls and rodents, which
are thought to have shared a common ancestor with hu-
mans over 80 million years ago (Nei et al. 2001; Nobrega
and Pennacchio 2004). In addition, we compared partial
protein sequences for nonmammalian vertebrates such as
chicken and ﬁsh, which diverged from humans approxi-
mately 300 and 400-450 million years ago, respectively
(Aparicio et al. 1995; Nei et al. 2001; Nobrega and Pen-
nacchio 2004) (Table 1).
We compared the PROP1 protein sequence for 13
mammals via a clustalW alignment (Fig. 1). Previous
PROP1 protein comparison illustrated high conservation
within the homeodomain (Guy et al. 2004). In addition, two
basic regions were identiﬁed within the homeodomain, B1
and B2, which are important for nuclear localization and
DNA binding of PROP1 (Guy et al. 2004) (Fig. 1, boxed
areas). The B1 and B2 regions are 100% identical between
human, pig (Sus scrofa), cow (Bos Taurus), dog (Canis
familiaris), mouse (Mus musculus), and rat (Rattus nor-
vegicus) (Guy et al. 2004). Our analysis shows that the
homeodomain is 100% conserved between humans, chim-
panzees (Pan troglodytes), gorillas, and baboons (Fig. 1,
shaded area and Table 1). In fact, the homeodomain region
is over 93% conserved between mouse and human (Fig. 1,
Table 1) and over 93% conserved between chicken (Gallus
gallus) and human (Table 1). Even very distantly related
vertebrate ﬁsh such as fugu (Fugu rubripes) and zebraﬁsh
(Danio rerio) show extensive conservation with human in
the PROP1 homeodomain region (Table 1). Although we
were surprised that the predicted ﬁsh proteins are much
more divergent from the mammalian proteins than the bird
(chicken), an extensive cladistic analysis of the paired
domains of ﬁsh and mammalian genes support the idea that
the ﬁsh sequences we present are the likely orthologs of the
mammalian sequences (data not shown). In addition, all of
the species that we analyzed had 100% identity in the B1
and B2 regions with the exception of the chicken, in which
only partial sequence was available (data not shown), and
the lemur, which had an in-frame deletion of R71 (Fig. 1,
indicated by white box). This is consistent with the
expectation that the homeodomain region is an important
functional region of the PROP1 protein because it has
evolved slowly compared to the other domains. To date all
of the mutations in the human population that are known to
cause MPHD as a result of PROP1 deﬁciency are predicted
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exception of the recently discovered nonsense mutation
that occurs in the transactivation domain. The homeodo-
main mutations include various missense mutations
(Fig. 1) as well as deletions, truncations, nonsense muta-
tions, and splicing mutations (Cushman and Camper 2001;
Parks et al. 1999; Reynaud et al. 2005). The homeodomain
also contains the point mutation of the Ames dwarf mouse
(Sornson et al. 1996) (Fig. 1). The transactivation domain
is also well conserved among mammals, ranging from
approximately 97%-98% identity between human and
other hominoids to 76.5% identity between human and
mouse (Fig. 1, Table 1). The N-terminus is the least con-
served domain of PROP1, with only approximately 80%
and approximately 78% identity between human and the
closely related capuchin and howler primates, respectively,
and less than 50% identity between human and mouse
(Fig. 1).
There are polymorphisms that occur within the PROP1
proteinofhumans,aswellasinthatofsheep,mice,andcows.
(Fig. 1). Allelic variants occur in the transactivation domain
in sheep (Ovis aries), T181A (Guy et al. 2004), cow, H173R
(Showalteretal.2002),andmouse,G155A,S171A,and208/
209 P insertion (Sornson et al. 1996). There is also a mouse
polymorphic deletion of one CA within a CA repeat in the
mouse UTR (Sornson et al. 1996). The human polymor-
phisms S20N, A51G, and G60E are located in the N-termi-
nus, while A142T (Nakamura et al. 1999b), is located in the
transactivation domain. The 21 additional human polymor-
phisms located in the noncoding sequence and silent muta-
tions within exons 1 and 2 are listed at the SNP NCBI site
(http://www.ncbi.nlm.nih.gov/). Although none of these
polymorphisms have been implicated in disease, they may
play a role in the genetic variation of quantitative traits
within the animal kingdom.
PROP1 sequence comparison reveals three conserved
noncoding elements
Previous studies using 5¢ RACE located the human PROP1
transcription initiation site 309 nucleotides upstream of the
translation initiation site (Duquesnoy et al. 1998). We
predicted the transcription initiation site of the mouse
Prop1 by comparing the mouse genomic sequence with the
consensus 5¢ sequence of four mouse Prop1 cDNA clones
obtained from full-length cap-trapper cDNA libraries
(Carninci et al. 2003). This revealed that the transcription
initiation site is located 353 nucleotides upstream of the
translation start site. This is 126 nucleotides upstream of
the previous transcription initiation site annotated by the
GenBank sequence NM008936 (http://www.ncbi.nlm.-
nih.gov/). Our results indicate a similar length for the hu-
man and mouse 5¢ UTR, but the sequence of this region is
poorly conserved (data not shown).
Table 1 The PROP1 homeodomain is highly conserved among vertebrate species
Description Organism Divergence from
Human (MYA)
a
PROP1 Protein Comparison (% ID to Human)
N-terminus Homeodomain Transactivation Total protein
Mammals Hominoid Chimpanzee 6–8 100 100 96.9 98.7
Gorilla 95.6 100 98 97.4
Old-world Baboon ~25 91.2 100 95.9 95.6
New-world Howler ~40 77.9 98.3 89.8 88.5
Capuchin 80.9 98.3 87.8 88.5
Prosimian Lemur ~60 66.2 90 84.7 80.2
Artiodactyl Pig ~80 66.2 96.7 82.7 81.5
Cow 47.1 96.7 80.6 74.9
Sheep 50 95 81.6 75.3
Carnivore Dog 57.4 93.3 85.7 79.3
Rodent Rat 51.5 90 71.4 70
Mouse 48.5 93.3 76.5 72.7
Non-mammals Bird Chicken ~300 n/a
b 93.6
c 69.4 n/a
Fish Fugu 400–450 n/a 81.7 25.5 n/a
Zebraﬁsh n/a 76.7 26.5 n/a
Tetraodon n/a 78.3 29.6 n/a
a MYA = million years ago
b n/a = not available
c partial protein sequence of the chicken PROP1 lacks ﬁrst few residues of the homeodomain
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human PROP1 with the orthologous region in mouse using
theUCSCgenomebrowser(http://www.genome.ucsc.edu/),
(Fig. 2A) (Kent et al. 2002). The nearest known 5¢ neigh-
boringgenetoPROP1isN4BP3,located118kbupstreamof
PROP1, and the nearest known 3¢ neighboring gene,
AK126616, is 34 kb downstream. In comparison, the nearest
5¢ and 3¢ genes to the mouse Prop1 gene are located 15 kb
(Olfr1378) and 7 kb (4933414115Rik) in distance, respec-
tively. This analysis also reveals that the mouse genomic
region orthologous to the approximately 620-kb ﬂanking
region5¢ofthehumanPROP1geneisinvertedandseparated
from mouse Prop1 by a series of olfactory genes that map to
human chromosomes 16 and 17 (Fig. 2A, lined box). An
approximately 760-kb region located approximately 750 kb
5¢ to the human PROP1 gene is present in the reverse ori-
entation 3¢ to the mouse Prop1 gene (Fig 2A, gray box).
Additional comparisons of the Prop1 locus between human
and chimpanzee and between rat and mouse reveal gene
orderconservationamongprimatesandamongrodents(data
not shown). A genome VISTA comparison of the pig Prop1
BAC to the mouse genome indicated gene order conserva-
tion (Couronne et al. 2003), suggesting that the region sur-
rounding the pig Prop1 locus is more similar to the mouse
Prop1 locus than to the human (Fig. 2B). These disruptions
in the gene order between the orthologous regions sur-
rounding the human and mouse or pig PROP1 genes may
obscure the identiﬁcation of conserved elements located at
great distances from the gene, but comparative genomics is
useful for the identiﬁcation of putative regulators within 26
kb that extends 5¢ and 3¢ from mouse Prop1 to the nearest-
neighboring genes.
To determine whether all of the elements necessary for
appropriate regulation of Prop1 transcription are contained
within a reasonably close distance to the gene, we sought to
rescue the Prop1 dwarf phenotype using a mouse BAC
containing Prop1. Prop1 mutants have profound, propor-
tional dwarﬁsm evident within the ﬁrst two weeks of life,
and adult mutants are approximately one third the size of
their normal littermates (Buckwalter et al. 1991). Further-
Fig. 1 PROP1 protein
comparison reveals lack of
conservation in the amino
terminal domain. The PROP1
protein sequence alignment for
12 mammals shows very high
conservation in the
homeodomain region (shaded
area) and in the transactivation
domain in the carboxy terminus.
The B1 and B2 regions within
the homeodomain are boxed.
The white box indicates the
deleted amino acid within the
B1 domain of the lemur.
Mutations in those amino acids
within the homeodomain region
that are known to cause MPHD
in humans (*) and mice (#) are
indicated. Allelic variants in the
sheep ($), cow (!), mouse (+),
and human (^) are indicated.
Human SNPs for PROP1 were
obtained from NCBI website
(http://www.ncbi.nlm.nih.gov/).
Arrows indicate the exon
boundaries. E1, exon 1; E2,
exon 2; E3, exon 3
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123more, their pituitaries have little or no GH, TSH, and PRL
and exhibit anterior lobe hypoplasia and overall pituitary
dysmorphology (Gage et al. 1996b; Nasonkin et al. 2004;
Ward et al. 2005). The mouse BAC RP23-250I22 is about
195 kb long and contains genomic sequence extending
from within the Olfr54 gene at the 5¢ end of Prop1 to the
Znf354c gene at the 3¢ of Prop1 (Fig. 2A, double arrow).
Therefore, this BAC contains additional sequence and
predicted genes past the immediate-neighboring genes for
Prop1. We injected this BAC into pronuclei of eggs de-
rived from a cross of wild-type and Prop1
+/df mice. Seven
transgenic lines were established, of which three were
Fig. 2 Mammalian genomic DNA sequence comparisons reveal the
presence of several highly conserved elements. A The approximate
position of BAC RP23-250122, used for transgene correction of the
Prop1-deﬁcient phenotype, is indicated at the top (double arrow),
aligned with the genome sequence from the mouse. Orthologous
regions of the human chromosome 5q35.3 and the mouse chromo-
some 11B1.3 reveal disruptions in gene order. An approximately 760-
kb region that is about 750 upstream of human PROP1 is inverted and
located approximately 10 kb 3¢ of the mouse Prop1 (gray box, arrow).
An approximately 620-kb region 5¢ to the human PROP1 is inverted
and located about 50 kb 5¢ to the mouse Prop1 (blue box, arrow). The
nearest genes 5¢ and 3¢ to both the human and the mouse PROP1
genes are shown. Large genes are indicated by black bars. The
PROP1 gene locus is indicated by the red box and red arrow. Scale
bar is marked in 175 kilobase (kb) increments. The arrow indicates
the orientation of the PROP1 gene. MMu, mouse orthologs to the
human 5q35.3 are indicated by a bracket and mouse chromosome
number. HSa, human orthologs to the mouse 11B1.3 are indicated by
a bracket and human chromosome number. B Genome VISTA plot
comparing the pig Prop1 BAC to the mouse genome revealing gene
order conservation. Colored peaks represent greater than 75% identity
over 100 bp. The mouse Zfp354b, Prop1, and Olfr1378 genes are
indicated by the arrows. C Pairwise comparisons are presented for
human vs. lemur, pig, and mouse. Colored peaks represent greater
than 75% identity over 100 bp. The regions of gene used for the
analysis of the conserved noncoding regions are indicated by the
black bars and dotted lines below the respective peaks. The PROP1
gene is indicated by the gray arrow. B, C x-axis, kilobases; y-axis,
percent identity ranging from 50% to 100%. Light blue, untranslated
regions (UTR); dark blue, coding regions; pink, conserved noncoding
regions; bp, base pairs; CE-A, conserved noncoding element A; CE-
B, conserved noncoding element B; CE-C, conserved noncoding
element C (URL: http://www-gsd.lbl.gov/VISTA/)
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123founded by Prop1
+/df mice and four by Prop1
+/+ mice. Two
BAC transgenic Prop1
+/+ lines were crossed to Prop1
+/df
mice to generate additional lines of BAC transgene;
Prop1
+/df. These transgenic heterozygotes were crossed to
Prop1
+/– mice to generate BAC transgene; Prop1
df/– mice
and other assorted genotypes. Prop1
df/– mice that harbor
the Prop1-containing BAC did not have a dwarf phenotype
but instead were equivalent in size to Prop1
+/+and Prop1
+/–
littermates (Fig. 3A, B). Of the ﬁve BAC transgenic lines
tested, three produced multiple offspring (n = 2-4) in
which the presence of the BAC rescued the Prop1
df/– dwarf
phenotype. Among these lines there were no cases of BAC
transgene; Prop1
df/– mice that were smaller than normal.
One line produced multiple offspring (n = 2) in which the
presence of the BAC did not rescue the Prop1
df/– dwarf
phenotype, suggesting that the BAC was not intact or
integrated in a region of the genome incompatible with
functionally appropriate expression. One line did not pro-
duce the desired combination of the BAC transgene with
Prop1
df/– in 30 pups examined, suggesting that the BAC
integrated on chromosome 11.
The BAC transgene; Prop1
df/– mice exhibiting pheno-
typic rescue of body size have a pituitary gland morphol-
ogy indistinguishable from that of wild-type littermates,
while nontransgenic Prop1
df/– mice have obviously hypo-
plastic anterior lobes (Fig. 3C). In addition, the BAC
transgene; Prop1
df/– pituitaries contained cells that express
PIT1 (Fig. 3D-F), GH, PRL, and TSH (data not shown),
which are essentially absent in the Prop1
df/– dwarf pitui-
taries. Therefore, the Prop1-containing BAC is able to
restore the pituitary cell types that are absent in the pitui-
taries of Prop1
df/– mice, as well as pituitary size, somatic
growth, and function of pituitary target organs.
We compared a 20-kb region of the human PROP1
genomic sequence with similar portions of genomic DNA
from three mammalian species: lemur, pig, and mouse. We
discovered regions in the noncoding sequence of PROP1
that are highly conserved over evolutionary time (Fig. 2C).
Approximately 10 kb of this sequence overlapped in all
four mammals and was analyzed by the mVISTA sequence
comparison program (Bray et al. 2003), which displays
regions of sequence conservation between two species that
are at least 100 bp long with 75% identity (Fig. 2C). The
human PROP1 gene is approximately 4 kb long and is
located in a region of the genome that contains relatively
few genes. Exons 2 and 3, which encode the HD and TA
domains (Fig. 1), are highly conserved among all four
species (Fig. 2C, blue peaks). Exon 1, however, is rela-
tively divergent among these species (Fig. 2C). The mVI-
STA plot also reveals three conserved noncoding
sequences among human, lemur, pig, and mouse (Fig. 2C,
pink peaks). The ﬁrst conserved element A (CE-A) is lo-
cated in the 5¢ ﬂanking sequence 9 bp upstream of the
mouse transcription initiation site and is 80.5% identical
between human and mouse over 312 bp (Fig. 2C). CE-B is
located within intron 1 of Prop1 and is 81.8% identical
Fig. 3 A Prop1 BAC transgene rescues the Prop1 mutant phenotype.
A Four sample mice and corresponding genotypes. Prop1
df/– mice are
dwarf, but the presence of the BAC transgene rescues the dwarf
phenotype. B The average weight of mice of each genotype is
graphed for all progeny of a cross of BAC transgenic; Prop1
df/
+ · Prop1
+/–. Error bars represent the standard deviation. For Prop1
+/
+ and Prop1
+/– mice, 116 mice were weighed at weaning, while 19
and 11 were weighed for Prop1
df/– and BAC transgenic; Prop1
df/–,
respectively. C Dissected pituitaries from P21 mice. The genotypes
are as follows: a = Prop1
+/+, b = BAC transgenic; Prop1
df/–,
c=Prop1
df/–. D-F PIT1 immunohistochemistry. The genotypes for
each image are as follows: D Prop1
+/+, E BAC transgenic; Prop1
df/–,
F Prop1
df/–
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123between human and mouse over 176 bp (Fig. 2C). The
third conserved region, CE-C, is the smallest conserved
noncoding element and is only 75.7% identical between
human and mouse with a length of approximately 100 bp
(Fig. 2C).
The Prop1 CE-A and CE-B regions show enhancer activity
in tissue culture
Various in vitro and in vivo methods have been used to test
the biological function of conserved elements discovered
by comparative genomics (Boffelli et al. 2003; Lettice
et al. 2003; Nobrega et al. 2003; Zerucha et al. 2000). CE-A
has no promoter activity in a heterologous CV1 monkey
kidney or the aT3 mouse gonadotrope-like cell lines (data
not shown). Therefore, CE-A, CE-B, and CE-C were ana-
lyzed for enhancer activity in tissue culture by inserting
each of them in both the forward and the reverse orienta-
tion upstream of the Drosophila alcohol dehydrogenase
(ADH) minimal promoter driving a luciferase (Luc) re-
porter gene (Fig. 4A, construct #1). The cell lines used for
the transfection assays included the CV-1, aT3, GH3 rat
somatotrope-like, and AtT-20 mouse corticotrope-like cell
lines. The enhancer activity of these elements is reported as
the fold increase in luciferase activity over the basal level
of the ADH-Luc vector alone.
A 584-bp Prop1 5¢ ﬂanking segment containing the CE-
A element from the mouse Prop1 gene was cloned into the
ADH-Luc vector in both forward and reverse orientations
(Figs. 2C and 4A, constructs #2 and #3, respectively). On
average, the CE-A (F)/ADH construct displayed about a
13.5-fold increase in activity in the CV-1 cells and
approximately 4-5-fold increase in activity in the GH3,
aT3-1, and AtT-20 cell lines (Fig. 4B). When the CE-A
was tested in the reverse orientation (Fig. 4A, construct
#3), the CE-A (R)/ADH showed no activity in any of the
cell lines tested, indicating that the effect is orientation-
dependent (Fig. 4B).
A 508-bp segment from intron 1 of the mouse Prop1
gene containing the CE-B element was also tested for en-
hancer activity in the ADH-Luc reporter construct
(Figs. 2C and 4A, constructs #4 and #5, respectively). The
CE-B (F)/ADH construct elicited, on average, a fourfold
increase in luciferase activity compared to the ADH-Luc
alone in the CV-1 cells (Fig. 4B). However, the CE-B (F)/
ADH had very low activity in the GH3 cells (less than a
twofold average increase over basal with a range of 1.1–
2.6-fold) and no activity in either the aT3-1 or the AtT-20
lines (Fig. 4B). The CE-B (R)/ADH construct showed no
enhancer activity in any of the cell lines tested (Fig. 4B).
A 1196-bp segment from the 3¢ ﬂanking sequence of the
mouse Prop1 gene containing CE-C was inserted into the
ADH-Luc reporter construct (Figs. 2C and 4A, constructs
#6 and #7, respectively). A larger section was used in the
analysis of the CE-C element because there were several
smaller peaks on the mVISTA plot between human and
mouse that showed signiﬁcant conservation between hu-
man and pig and between human and lemur that ﬂanked the
CE-C segment (Fig. 2C). The CE-C in either orientation
appeared to have no enhancer activity in the aT3-1 or the
GH3 cell lines but did have a low level of activity in the
forward orientation when tested in the CV-1 and AtT-20
cell lines (Fig. 4B).
In summary, the 5¢ element CE-A had the highest
activity with the ADH-Luc reporter. The CE-B intronic
element and the CE-C 3¢ element had low orientation-
dependent enhancer activity in the CV-1 cells and very
low, if any, activity in the pituitary-derived cell lines. This
was not surprising because these pituitary cell types are
derived from differentiated pituitary cells and do not ex-
press endogenous Prop1. These pituitary-like cells may not
have all the components necessary to allow for the proper
function of all of the Prop1 enhancer elements or they may
contain factors that repress the function of these elements.
The Prop1 CE-A element is not sufﬁcient for LacZ
expression in transgenic mice
The CE-A and CE-B regions were also analyzed in trans-
genic mice to determine whether they function in vivo. CE-
A/LacZ (Table 2), which consists of a 3-kb region imme-
diately 5¢ to the Prop1 ATG containing the 5¢ UTR, the
Prop1 transcription initiation site, and the CE-A region,
was analyzed for the ability to drive the expression of a
nuclear localized E. coli b-galactosidase-mouse protamine
1 reporter construct (LacZ-pA) in transgenic mice
(Fig. 2C). Transgenic founders were bred to produce lines
for embryo analysis, or transient transgenic embryos were
harvested and analyzed for the transgenic transcript via
in situ hybridization (ISH) at e12.5 because this is the time
of peak Prop1 expression (Sornson et al. 1996). We used
the well-characterized aGsu-LacZ and aGsu-Prop1
transgenes as positive controls for detecting b-galactosi-
dase activity in the pituitary gland by X-gal staining and for
mouse protamine ISH, respectively (Cushman et al. 2001;
Kendall et al. 1994). The promoter and enhancer sequences
of the pituitary glycoprotein hormone a-subunit gene (Cga
for chorionic subunit a or aGsu) are sufﬁcient to drive
expression of LacZ and other reporters in a manner that is
developmentally, hormonally, and tissue-speciﬁcally cor-
rect (Kendall et al. 1994). Both the aGsu-LacZ transgenic
mice and the aGsu-Prop1 transgenic mice contain the
mouse protamine splice sites and polyadenylylation se-
quences that can be used as a transgene-speciﬁc tag in any
organ except the testis, which expresses the endogenous
protamine gene. None of the ﬁve transgenic embryos
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gene compared with positive controls. Thus, the 3-kb 5¢
ﬂanking region of Prop1 is not sufﬁcient for transgene
expression. The intronic CE-B element was tested in con-
junction with CE-A for in vivo Prop1 expression. Trans-
genic mice were made with the construct CE-B+CE-A/
LacZ, which contains CE-B upstream of the Prop1 3-kb 5¢
ﬂanking region (Fig. 2C, Table 2). Fifteen transient trans-
genic embryos were harvested at e12.5 and assayed for
expression of the transgene by either X-gal staining or ISH
for mP1. None of the 15 embryos analyzed had detectable
expression of the transgene, although the positive controls
did exhibit expression. Thus, the combination of CE-B and
CE-A is also not sufﬁcient for expression in vivo.
The Prop1 CE-B putative enhancer is important for spatial
expression in transgenic mice
The CE-B region was tested for enhancer function in
transgenic mice in the context of the aGsu promoter. The
ﬁrst clues to a possible role for CE-B in the expression of
Prop1 came from the analysis of the aGsu-Prop1 trans-
genic mice (Table 2). Endogenous Prop1 is normally ex-
pressed from e9 until e15.5 in the mouse in a dorsal
(highest) to ventral (lowest) expression gradient (Fig. 5A)
(Sornson et al. 1996). In contrast, aGsu is expressed during
pituitary development in the caudomedial and ventral
portions of the pituitary where the thyrotropes and go-
nadotropes arise, and its expression continues in these two
cell types throughout adulthood (Fig. 5B) (Japon et al.
1994; Kendall et al., 1994; Raetzman et al. 2002). Ten
stable lines were created with the aGsu-Prop1 transgene
and six expressed the transgene in the adult pituitary. Two
lines were maintained and analyzed (Cushman et al. 2001).
These studies revealed that the aGsu-Prop1 construct
yields efﬁcient overexpression of Prop1 beyond e15.5
(Cushman et al. 2001). Expression of the aGsu-Prop1
transgene is expanded dorsally beyond the normal
expression domain of endogenous aGsu and beyond that
observed for other aGsu driving expression of LacZ or
other reporters. This dorsal expression is observed in
pituitaries at postnatal day 1 (P1, day of birth) in 2/2 stable
transgenic lines and at e18.5 in 3/3 transient transgenics
that were created with the same aGsu-Prop1 construct.
This expression pattern appears to be a combination of both
endogenous aGsu and Prop1 (compare Fig. 5C with B and
A). This result suggests that the CE-B region is important
for the dorsal expansion of the aGsu-Prop1 transgene and
Fig. 4 Enhancer study of
Prop1 conserved noncoding
elements from the mouse gene
in monkey kidney CV-1, GH3
(rat somato-lactotropes), aT3-1
(mouse gonadotrope-like), and
AtT-20 (mouse corticotrope-
like) cells. A Diagram of the
conserved elements upstream of
the ADH-Luc reporter construct.
B Luciferase activity as fold
activation over basal shown for
the constructs depicted in (A)
for CV-1, GH3, aT3-1, and
AtT-20 cells reveal orientation-
dependent enhancer activity for
CE-A in all lines and for CE-B
in CV-1 and GH3 lines. ADH,
alcohol dehydrogenase minimal
promoter; LUC, luciferase
reporter gene; F, forward
orientation; R, reverse
orientation. The asterisk
designates constructs with
activity signiﬁcantly above
baseline
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123thus important for the spatial expression of endogenous
Prop1.
We tested the signiﬁcance of CE-B for dorsalized trans-
gene expression by deleting CE-B from intron 1 to produce
the construct aGsu-Prop1DCE-B (Table 2). Transient
transgenics bearing this construct were harvested at P1 and
assayed for the expression of the transgene using ISH for
Prop1. Six of the eight transgenic mice analyzed exhibited
transgene expression. One had very weak expression and
was eliminated from further consideration. The remaining
ﬁve had strong expression. In these ﬁve transgenic mice, the
expression pattern of the aGsu-Prop1DCE-B transgene is
restrictedtotheventralaspectsofthepituitary,typicalforthe
aGsupromoterandenhancer(compareFig. 5DwithC).This
result indicates that CE-B was necessary for the dorsal
expression of the aGsu-Prop1 construct.
To determine whether the position of the CE-B relative
to the aGsu promoter is critical, the CE-B region was re-
placed in the aGsu-Prop1DCE-B construct upstream of the
aGsu promoter to create a new construct, CE-B + aGsu-
Prop1DCE-B (Table 2). The CE-B + aGsu-Prop1DCE-B
transgenic mice were harvested at P1 and assayed for
expression of the transgene. The CE-B + aGsu-Prop1DCE-
B transgene expression was expanded to the dorsal aspect
of the pituitary in six of seven transient lines (Fig. 5E),
with the remaining line having only weak expression of the
transgene. Finally, an ISH for Prop1 on nontransgenic
pituitaries gave no signal (Fig. 5F), thus verifying that the
patterns of expression seen in Figs. 5C, D, F are due to the
speciﬁc transgene. The transgenic analysis provided in vivo
evidence that the CE-B contained within the intron 1 of
Prop1 is sufﬁcient to confer spatial expression information
in a position-independent manner in the context of the
transgene.
Discussion
We sought to identify cis-acting DNA sequences important
for mouse Prop1 expression because regulation of Prop1 is
important for normal pituitary development and function.
To accomplish this, we obtained genomic sequence from
lemur and pig (Sus scrofa) PROP1 BACs and compared
these to PROP1 sequences available online (Ahituv et al.
2004; Aparicio et al. 1995; Boffelli et al. 2003, 2004;
Nobrega and Pennacchio 2004; Williams et al. 2003). We
also generated PROP1 genomic sequence for the ﬁrst time
for ﬁve different primate species to include in the com-
parison. We identiﬁed three conserved noncoding elements
(CE) that are larger than 100 bp with greater than 75%
identity between human and mouse and tested them for
function in cell culture and transgenic mice. The three re-
Table 2 Transgenic constructs used to test the in vivo function of the conserved non-coding elements of the mouse Prop 1 gene
R.D. Ward et al.: Transcriptional Control Sequences in the Prop1 Gene 533
123gions that ﬁt these criteria are CE-A, a 300-bp region in the
Prop1 promoter proximal region; CE-B, a 200-bp region
within the ﬁrst intron of Prop1; and CE-C, a 103-bp region
within the 3¢ ﬂanking sequence.
Transfection of cultured cells has been successful for
demonstrating the function of some elements (Nishimura
et al. 2000; Surinya et al. 1998; Swamynathan and Piati-
gorsky 2002), but there are examples of important regu-
latory sequences that are not identiﬁed with this approach
(Lang et al. 2003; Lettice et al. 2003; Nobrega et al. 2003;
Zerucha et al. 2000). Prop1 is expressed in a distinct
spatial-, temporal-, and tissue-speciﬁc fashion during
development, and the endogenous gene is not expressed in
any of the available pituitary cell lines. Nevertheless, CE-A
exhibited orientation-dependent activity in all cell lines.
CE-B, located within intron 1 of Prop1, also appeared to
have orientation-dependent enhancer activity in CV-1 cells
and GH3 cells, although at a much lower level. There was
Fig. 5 Transgenic mice reveal functional properties of CE-B. A
Endogenous Prop1 expression illustrated diagrammatically and with
Prop1 in situ hybridization in sagittal e12.5 and e14.5 mouse and
coronal e14.5 pituitaries. A dorsal-to-ventral expression gradient is
apparent. The anterior lobe is marked by a black line. B
Immunohistochemical staining with aGSU antibody (brown DAB
chromagen) reveals normal aGsu expression in the caudomedial and
ventral regions of a P1 coronal pituitary expression via IHC. C In situ
hybridization for Prop1 transcripts [purple AP chromagen] reveals
that the aGsu-Prop1 transgenic construct expression is expanded
dorsally in P1 coronal pituitary sections relative to endogenous aGsu
expression. D Prop1 in situ hybridization shows that the aGsu-
Prop1DCE-B transgenic construct expression (purple AP chromagen)
was restored to the caudomedial and ventral regions in P1 coronal
pituitaries. E Prop1 in situ hybridization shows that the CE-B + aGsu
Prop1DCE-B transgenic expression (purple AP chromagen) was
expanded to the dorsal aspects of the pituitary at P1. C–E
Representations of the transgenic constructs are shown beneath the
appropriate studies. Brackets mark the region for each pituitary in
which the transgene expression was detected. F In situ hybridization
for Prop1 in a nontransgenic pituitary gives no signal. DAB, 3,3¢
diaminobenzidine; AP, alkaline phosphatase; A, anterior lobe; P,
posterior lobe; I, intermediate lobe; RP, Rathke’s pouch; INF,
inﬁndibulum; v, ventral expression pattern; d + v, dorsal and ventral
expression pattern
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123no enhancer activity in either the AtT-20 line or the aT3-1
line. The CE-C putative regulatory element had low en-
hancer activity in only the CV-1 and AtT-20 cell lines.
There are many possible explanations for the weak activity
of CE-B and CE-C in cell culture, but the cell culture as-
says did detect enhancer function. The pituitary-derived
cell lines were developed in the different hormone-pro-
ducing cell lineages, e.g., the aT3-1 cells are gonadotrope-
like, whereas GH3 cells are somatotrope-like. Therefore,
the differential enhancer activities of the different con-
structs in these cell lines may be examples of context-
speciﬁc activity. In addition, the cell lines may be more
representative of differentiated cell types and, because
Prop1 is expressed signiﬁcantly only during early pituitary
development in the rodent (Sornson et al., 1996), these
cells may not contain the transcription factors and cofactors
necessary for the full activity of the putative enhancers.
These enhancers also are orientation-speciﬁc. However,
other examples of orientation-dependent enhancers have
been reported (Cheng et al. 2004; Falvo et al. 2000; Ni-
shimura et al. 2000; Surinya et al. 1998; Swamynathan and
Piatigorsky 2002; Wei and Brennan 2000).
Our transgenic experiments shed some light on the
function of the CE-B region. In the context of the aGsu
promoter, the CE-B element results in dorsal expansion of
transgene expression. Although this construct used a het-
erologous promoter, which allows for the expression of the
transgene after the endogenous Prop1 expression is extin-
guished, these results provide evidence that the CE-B re-
gion in intron 1 of Prop1 is important for spatial
expression. The CE-B region in conjunction with the aGsu
promoter will be useful for driving the expression of
transgenes in the more dorsal aspects of the developing
pituitary. Other studies have shown that the Rbp-Jj DNA
binding protein, which is the primary mediator of Notch
signaling, can directly bind to intron 1 of Prop1 and is
important for the maintenance of Prop1 expression (Zhu
et al. 2006). Taken together, these data suggest an in vivo
role for the CE-B in the regulation of Prop1 expression.
Two kilobase pairs of the Prop1 promoter proximal
region (CE-A) is inadequate for reporter gene expression in
transgenic mice, even in the context of CE-B. This indi-
cates that additional sequences are necessary for Prop1
expression in mice. The BAC rescue of Prop1
–/df mice
demonstrates that all of the elements necessary for tran-
scriptional regulation of Prop1 are contained within the
BAC. We predict that the remaining critical sequences for
Prop1 expression are within the region immediately sur-
rounding Prop1, within 15 kb upstream and approximately
26 kb downstream, because there is a disruption in gene
order between human and mouse or pig. These critical
control sequences are not readily identiﬁable by genomic
sequence comparisons.
In summary, we identiﬁed a region, contained within
intron 1 of Prop1, which is necessary and sufﬁcient for the
spatial expression of Prop1 in the context of a heterologous
pituitary speciﬁc promoter. While additional regulatory
elements remain to be identiﬁed by other approaches, the
intronic element is worth screening for mutations in
unexplained cases of MPHD patients, especially those that
appear heterozygous for mutations in PROP1.
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